黄类药物的神经保护作用:作为点的内质网膜
Bita Amiri1,2, Maryam Yazdani Tabrizi1,2, Mahdyieh Naziri3
1Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Frontiers in neuroscience
|July 3, 2024
概括
来自植物的天然化合物黄类化合物,通过减少内质网膜 (ER) 压力,显示出对抗神经系统疾病的前景. 本综述探讨了它们通过调节ER压力路径来治疗神经退行性疾病的潜力.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 神经系统疾病,特别是与年龄有关的神经退行性疾病,正在增加.
- 目前的治疗方法对这些疾病的治疗方法有限.
- 由错误折叠的蛋白质积累引起的内质网膜 (ER) 压力是神经系统疾病的常见因素.
研究的目的:
- 审查黄类药物作为神经系统疾病治疗药物的潜力.
- 为了检查黄类药物如何调节内质网膜 (ER) 压力.
- 探索神经退行性疾病中黄类药物的作用机制.
主要方法:
- 关于黄类药物和ER压力的科学研究的文献综述.
- 对黄类子类及其化学结构的分析.
- 检查关于黄类抗氧化剂活性和细胞灭绝和自的调节的研究.
主要成果:
- 黄类,是一种多样化的植物多类,具有抗氧化特性.
- 黄类药物可以抑制活性氧物种 (ROS) 的形成.
- 研究表明,黄类药物通过亡和自途径调节ER压力.
结论:
- 黄类药物显示出作为神经退行性疾病的新型治疗剂的潜力.
- 了解ER压力中的黄胺机制对于开发新疗法至关重要.
- 对黄胺的进一步研究可能会导致对神经疾病的有效干预.
关键词:
阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.加瓦赞格路是加瓦赞格路.伊朗的黄类化合物帕金森病是帕金森氏症的一种疾病.这就是ZUMMS.赞扬 赞扬 赞扬 赞扬细胞内膜网膜的压力应激神经系统疾病 神经系统疾病更多相关视频
相关概念视频
Export of Misfolded Proteins out of the ER
3.6K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.6K
Protein Folding Quality Check in the RER
3.7K
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
3.7K
ER Retrieval Pathway
3.8K
In the secretory pathway, vesicles transport proteins from one cellular compartment to another in forward transport to deliver the protein to its correct location. Occasionally, misfolded proteins and incorrect proteins escape their original compartments, and a retrieval pathway is used to return the escaped proteins to their original compartment.
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
3.8K
Protein Modifications in the RER
5.1K
Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
5.1K
The Endoplasmic Reticulum
13.0K
The endoplasmic reticulum or ER makes up for more than half of the membranes in a cell and accounts for 10% of total cell volume. It is also the primary protein and lipid synthesis factory for most cell organelles, such as the Golgi apparatus, lysosomes, secretory vesicles, and the plasma membrane. Despite being the most extensive and functionally complex subcellular organelle, ER was the last to be discovered. After years of deliberation, Keith Porter and George Palade in the year 1954,...
13.0K
Tail-anchoring of Proteins in the ER Membrane
3.1K
Tail-anchored, or TA, proteins are estimated to make up to 3-5% of membrane proteins found in the eukaryotic cell. Such proteins have a single transmembrane domain located approximately 30 amino acid residues upstream from the C-terminal end. As a result, the signal recognition particle (SRP) cannot guide a TA protein to the ER membrane for cotranslational insertion. Hence, they are integrated into the ER membrane post-translationally using their C-terminal end as the anchor. TA proteins...
3.1K


